HRP20100027T1 - Upotreba kompleksnih spojeva željeza (iii) - Google Patents

Upotreba kompleksnih spojeva željeza (iii) Download PDF

Info

Publication number
HRP20100027T1
HRP20100027T1 HR20100027T HRP20100027T HRP20100027T1 HR P20100027 T1 HRP20100027 T1 HR P20100027T1 HR 20100027 T HR20100027 T HR 20100027T HR P20100027 T HRP20100027 T HR P20100027T HR P20100027 T1 HRP20100027 T1 HR P20100027T1
Authority
HR
Croatia
Prior art keywords
iron
iii
use according
maltodextrins
compounds
Prior art date
Application number
HR20100027T
Other languages
English (en)
Croatian (hr)
Inventor
Tanner-Baumgartner Jessica
Chandra Ranjeet
Geisser Peter
Original Assignee
Vifor (International) Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor (International) Ag filed Critical Vifor (International) Ag
Publication of HRP20100027T1 publication Critical patent/HRP20100027T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20100027T 2005-02-09 2006-01-18 Upotreba kompleksnih spojeva željeza (iii) HRP20100027T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100907 2005-02-09
PCT/EP2006/050276 WO2006084782A1 (de) 2005-02-09 2006-01-18 Verwendung von eisen(iii)-komplexverbindungen

Publications (1)

Publication Number Publication Date
HRP20100027T1 true HRP20100027T1 (hr) 2010-02-28

Family

ID=34938674

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100027T HRP20100027T1 (hr) 2005-02-09 2006-01-18 Upotreba kompleksnih spojeva željeza (iii)

Country Status (26)

Country Link
US (2) US8722101B2 (da)
EP (1) EP1848446B1 (da)
JP (1) JP5060312B2 (da)
KR (1) KR20070107106A (da)
CN (1) CN101155593A (da)
AT (1) ATE445406T1 (da)
AU (1) AU2006212322B2 (da)
BR (1) BRPI0606974A2 (da)
CA (1) CA2597154C (da)
CR (1) CR9300A (da)
CY (1) CY1109685T1 (da)
DE (1) DE502006005100D1 (da)
DK (1) DK1848446T3 (da)
ES (1) ES2333814T3 (da)
HR (1) HRP20100027T1 (da)
IL (1) IL185020A (da)
MX (1) MX2007009588A (da)
NO (1) NO20074536L (da)
PL (1) PL1848446T3 (da)
PT (1) PT1848446E (da)
RU (1) RU2359680C2 (da)
SI (1) SI1848446T1 (da)
TN (1) TNSN07307A1 (da)
UA (1) UA88347C2 (da)
WO (1) WO2006084782A1 (da)
ZA (1) ZA200707716B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
PT1973549T (pt) 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro
EP2165713B1 (en) * 2008-09-19 2012-11-14 Nestec S.A. Whey and thymus function
LT3156075T (lt) 2009-03-25 2021-01-11 Pharmacosmos Holding A/S Oligosacharidas ir jo paruošimo būdas
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
US11395502B2 (en) * 2012-10-18 2022-07-26 Patrick Monsivais Formulation for iron supplements
EP2978427B1 (de) * 2013-03-28 2018-08-08 Vifor (International) AG Fe(iii)-komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
KR20150078375A (ko) * 2013-12-30 2015-07-08 한화케미칼 주식회사 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물
FR3075001B1 (fr) * 2017-12-14 2021-09-10 Tereos Starch & Sweeteners Belgium Utilisation des maltodextrines pour ameliorer la cognition et/ou stimuler le developpement du cerveau
CN114288320A (zh) * 2021-12-29 2022-04-08 珠海天翼医药技术开发有限公司 一种猪用口服补铁剂及其制备方法
KR20250046064A (ko) 2023-09-26 2025-04-02 주식회사 페라메드 신규한 착화합물, 그를 포함하는 방사선 노출로 인한 조혈 기능 장애 질환의 예방 또는 치료용 약학 조성물 및 그의 제조방법
KR20250110406A (ko) 2024-01-11 2025-07-21 주식회사 페라메드 신규한 착화합물을 이용한 핵산의 증폭 유무를 판별하는 방법
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076798A (en) * 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3766165A (en) * 1966-08-17 1973-10-16 Pfizer Polysaccharides and their preparation
DE4421159C1 (de) * 1994-06-20 1995-08-24 Thomas Bruns Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
RU2158595C1 (ru) * 1999-07-07 2000-11-10 Латыпова Лилия Фуатовна Способ лечения иммунопатий при железодефицитной анемии у часто болеющих детей, проживающих в крупном промышленном городе с развитой химической и нефтехимической промышленностью
AU2002220280A1 (en) * 2000-12-07 2002-06-18 Ad "Zdravlje" Farmaceutsko - Hemijska Industrija, Centar Za Istrazivanje I Razvoj Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
KR20040026136A (ko) * 2001-04-10 2004-03-27 다니스코 유에스에이 인코포레이티드 단당류 및 이당류를 모노카르복실산 및 락톤과 중합시키는방법
RU2208440C2 (ru) * 2001-07-20 2003-07-20 Иркутский институт химии им. А.Е. Фаворского СО РАН Средство, обладающее противоанемической и иммуномодуляторной активностью
AU2003226923B2 (en) 2002-04-09 2006-08-17 Pharmacosmos Holding A/S iron dextrin compounds for the treatment of iron deficiency anaemia
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
AU2006212322A1 (en) 2006-08-17
US8722101B2 (en) 2014-05-13
CR9300A (es) 2007-12-07
CY1109685T1 (el) 2014-08-13
EP1848446B1 (de) 2009-10-14
PT1848446E (pt) 2009-12-21
US20080214496A1 (en) 2008-09-04
IL185020A (en) 2013-10-31
CN101155593A (zh) 2008-04-02
MX2007009588A (es) 2007-09-12
ZA200707716B (en) 2008-06-25
JP5060312B2 (ja) 2012-10-31
IL185020A0 (en) 2007-12-03
NO20074536L (no) 2007-11-05
JP2008530049A (ja) 2008-08-07
EP1848446A1 (de) 2007-10-31
TNSN07307A1 (en) 2008-12-31
UA88347C2 (ru) 2009-10-12
CA2597154C (en) 2011-03-15
CA2597154A1 (en) 2006-08-17
KR20070107106A (ko) 2007-11-06
ATE445406T1 (de) 2009-10-15
ES2333814T3 (es) 2010-03-01
WO2006084782A1 (de) 2006-08-17
AU2006212322B2 (en) 2012-01-19
SI1848446T1 (sl) 2010-01-29
RU2359680C2 (ru) 2009-06-27
RU2007133509A (ru) 2009-03-20
US20140187514A1 (en) 2014-07-03
PL1848446T3 (pl) 2010-03-31
DK1848446T3 (da) 2010-02-15
BRPI0606974A2 (pt) 2009-07-28
DE502006005100D1 (de) 2009-11-26

Similar Documents

Publication Publication Date Title
HRP20100027T1 (hr) Upotreba kompleksnih spojeva željeza (iii)
BR0315452A (pt) Complexos aquosos de carboidrato de ferro, sua produção e medicamentos contendo os mesmos
RU2002106399A (ru) Составы моксифлоксацина, содержащие поваренную соль
ATE464883T1 (de) Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
RU2009110912A (ru) Средство и продукт питания для профилактики/уменьшения проявлений функционального расстройства пищеварения
TN2009000443A1 (en) Water-soluble iron-carbohydrate derivative complexes, the preparation thereof, and medicaments comprising them
CN101312746B (zh) 包括铁(ⅲ)络合化合物和一种或多种氧化还原活性物质的制剂
KR950007845A (ko) 신장 질환용 약제학적 조성물 및 인공 신장용 투석액
RU2008111148A (ru) Применение комплексных соединений железа (iii) для производства лекарственного средства для перорального лечения железодефицитных состояний у больных, страдающих хроническими воспалительными заболеваниями кишечника
RU2018101220A (ru) Продукт на основе хелата бис-глицината железа и альгиновой кислоты и/или ее водорастворимых солей, его составы и его фармацевтические применения
HRP20220691T1 (hr) Poboljšanja u i u vezi s pripravcima
RU2217141C1 (ru) Состав "витализин-1" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний
ATE281832T1 (de) Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin
RU2000103880A (ru) Способ моделирования цирроза печени
RU2217138C1 (ru) Состав "витализин-2" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний
RU2002120934A (ru) Биологически активная добавка к пище
JP2008115185A5 (da)
EA200702256A1 (ru) Микросферический васкулярный эмбол на основе альгината натрия,содержащий гинекологическое лекарственное средство, и его получение
TH2003002835C3 (th) วิตามินผสม
CN101544690A (zh) 从墨草(P.octandra)所提取的一类植物蛋白、其制备方法及用途
JPS584724A (ja) 免疫賦活剤
CN102816348A (zh) 一种壳聚糖天冬氨酸琥珀酸复合盐及其作为增鲜剂的应用
RU2000103102A (ru) Способ моделирования токсической гепатопатии
JP2013053135A (ja) 内服製剤
KR20190007675A (ko) 황칠소금의 제조방법